Jay Koyner United States

Jay L. Koyner, MD, is a Professor of Medicine in the Section of Nephrology at the University of Chicago where he also serves as the Medical Director of the Inpatient Dialysis Unit, Director of ICU Nephrology and the Associate Program Director of the Nephrology-Critical Care Fellowship. His clinical and research focus centers on critical care nephrology including the earlier detection of acute kidney injury (AKI) using machine-learning risk scores and novel biomarkers of tubular injury. Additional interests include improving the care delivery of patients with AKI especially those receiving continuous renal replacement therapy. Dr. Koyner is a national and international leader in AKI research. He has contributed to several multicenter studies investigating the biomarkers of AKI, including the TRIBE-AKI and several industry sponsored studies. This work has led to the development and FDA approval of several new biomarkers as well as the standardization of the furosemide stress test. Having worked to bring these tools from research studies to everyday clinical use, his work has improved the care of patients at risk for AKI as well as those with established early AKI. In addition to his research efforts, Dr. Koyner is an accomplished educator, having created and directed the University of Chicago’s Nephrology fellowship’s Intensive Care Unit rotations. On the national level he has directed the American Society of Nephrology’s Critical Care Nephrology pre-course and edited the Nephrology Self-Assessment Program (NephSAP) for Acute Kidney Injury and Critical Care Nephrology. More recently he has served as the primary editor of the Handbook of Critical Care Nephrology. Dr. Koyner is actively involved in training the next generation of critical care nephrologists. He has published over 200 peer-reviewed research articles, review papers, editorials, book chapters, and consensus care documents.